CoChat
Sign Up
Cited by 29

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

The mystery of the Hawaii liver disease cluster in summer 2013: A pragmatic and clinical approach to solve the problem

Teschke, Rolf, Schwarzenboeck, Alexander, Frenzel, Christian, Schulze, Johannes, Eickhoff, Axel, Wolff, Albrecht·2016·Annals of Hepatology
DOI 10.5604/16652681.1184237
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5604/16652681.1184237

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 64

  1. Cohen, 2014, Hazards of hindsight - monitoring the safety of nutritional supplements, N Engl J Med, 370, 1277, 10.1056/NEJMp1315559 · DOI · Paper page
  2. 2013, Acute hepatitis and liver failure following use of a dietary supplement intended for weight loss or muscle building May-October 2013, MMWR Morb Mortal Wkly Rep, 62, 817
  3. Fares, 2012, Seasonable of viral hepatitis, J Acad Med Sci, 2, 110, 10.4103/2249-4855.132952 · DOI
  4. Hoofnagle, 2012, Review article: hepatitis E, N Engl J Med, 367, 1237, 10.1056/NEJMra1204512 · DOI
  5. Pavio, 2010, Zoonotic hepatitis E: animal reservoirs and emerging risks, Vet Res, 41, 46, 10.1051/vetres/2010018 · DOI
  6. Fujiwara, 2014, Chronic hepatitis E: A review of the literature, J Viral Hepat, 2, 78, 10.1111/jvh.12156 · DOI
  7. Li, 2005, Hepatitis E virus transmission from wild boar meat, Emerg Infect Dis, 11, 1958, 10.3201/eid1112.051041 · DOI
  8. Meng, 2000, Zoonotic and xenozoonotic risks of the hepatitis E virus, Infect Dis Rev, 2, 35
  9. Tei, 2003, Zoonotic transmission of hepatitis E virus from deer to human beings, Lancet, 362, 371, 10.1016/S0140-6736(03)14025-1 · DOI
  10. Masuda, 2005, Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan, Hepatol Res, 31, 178, 10.1016/j.hepres.2005.01.008 · DOI
  11. Matsuda, 2003, Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar, J Infect Dis, 188, 944, 10.1086/378074 · DOI
  12. Kabrane-Lazizi, 1999, Evidence for widespread infection of wild rats with hepatitis E virus in the United States, Am J Trop ed Hyg, 61, 331, 10.4269/ajtmh.1999.61.331 · DOI
  13. Davern, 2011, Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury, Gastroenterology, 141, 1665, 10.1053/j.gastro.2011.07.051 · DOI
  14. Dalton, 2007, The role of hepatitis E virus testing in drug-induced liver injury, Aliment Pharmacol Ther, 26, 1429, 10.1111/j.1365-2036.2007.03504.x · DOI
  15. Teschke, 2015, Clinical review: Herbal hepatotoxicity and the call for systematic data documentation of individual cases, J Liver Clin Res, 2, 1008
  16. Roytman, 2014, Letter to the Editor: Outbreak of severe hepatitis linked to weight-loss supplement OxyElite Pro, Am J Gastroenterol, 109, 1296, 10.1038/ajg.2014.159 · DOI
  17. Teschke R, Schulze J, Eickhoff A, Wolff A, Frenzel C. Review article: Mysterious Hawaii liver disease case - Naproxen overdose as cause rather than OxyELITE Pro? J Liver Clin Res 2015; 2. Available at: http://www.jscimedcentral.com/Liver/liver-2-1013.pdf
  18. Smilkstein, 1988, Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose, N Engl J Med, 319, 1557, 10.1056/NEJM198812153192401 · DOI · Paper page
  19. Kamar, 2014, Ribavirin for chronic hepatitis E virus infection in transplant recipients, N Engl J Med, 370, 1111, 10.1056/NEJMoa1215246 · DOI
  20. Lok, 2009, Chronic hepatitis B: Update 2009, Hepatology, 50, 1, 10.1002/hep.23190 · DOI
  21. Zuckerman, 2013, Varicella zoster virus (VZV) and herpes simplex virus (HSV) in solid organ transplant patients, Am J Transplant, 13, 55, 10.1111/ajt.12003 · DOI
  22. Ahmed, 2011, Antiviral treatment of cytomegalovirus infection, Infect Disord Drug Targets, 11, 475, 10.2174/187152611797636640 · DOI
  23. Teschke, 2015, Editorial. Drug-induced liver injury: Expanding our knowledge by enlarging population analysis with prospective and scoring causality assessment, Gastroenterology, 148, 1271, 10.1053/j.gastro.2015.04.027 · DOI
  24. Teschke, 2015, Herbal hepatotoxicity in traditional and modern medicine: Actual key issues and new encouraging steps, Front Pharmacol, 6, 1, 10.3389/fphar.2015.00072 · DOI · Paper page
  25. Aithal, 2011, Case definition and phenotype standardization in drug-induced liver injury, Clin Pharmacol Ther, 89, 806, 10.1038/clpt.2011.58 · DOI · Paper page
  26. Andrade, 2009, Drug-induced liver injury: insights from genetic studies, Pharmacogenomics, 10, 1467, 10.2217/pgs.09.111 · DOI
  27. Nainan, 2006, Diagnosis of hepatitis A virus infection: a molecular approach, Clin Microbiol Rev, 19, 63, 10.1128/CMR.19.1.63-79.2006 · DOI
  28. Bharti, 2003, Peru-United States Leptospirosis Consortium. Leptospirosis: a zoonotic disease of global importance, Lancet Infect Dis, 3, 757, 10.1016/S1473-3099(03)00830-2 · DOI
  29. Tandon, 1978, Epidemic of toxic hepatitis in India of possible mycotoxic origin, Arch Pathol Lab Med, 102, 372
  30. Anfossi, 2008, Development and application of solvent-free extraction for the detection of aflatoxin M1 in dairy products by enzyme immunoassay, J Agric Food Chem, 56, 1852, 10.1021/jf073133d · DOI
  31. Azziz-Baumgartner, 2005, Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004, Environ Health Perspect, 113, 1779, 10.1289/ehp.8384 · DOI
  32. Ferrer Amate, 2010, Development and validation of a LCMS/MS method for the simultaneous determination of aflatoxins, dyes and pesticides in spices, Anal Bioanal Chem, 397, 93, 10.1007/s00216-010-3526-x · DOI
  33. Garon, 2010, FT-IR spectroscopy for rapid differentiation of Aspergillus flavus, Aspergillus fumigatus, Aspergillus parasiticus and characterization of aflatoxigenic isolates collected from agricultural environments, Mycopathologica, 170, 131, 10.1007/s11046-010-9304-7 · DOI
  34. Huang, 2010, Simultaneous determination of aflatoxins B1, B2, G1, G2, M1 and M2 in peanuts and their derivative products by ultra-high-performance liquid chromatography-tandem mass spectrometry, Anal Chim Acta, 662, 62, 10.1016/j.aca.2010.01.002 · DOI
  35. Lupo, 2010, Validation study of a rapid ELISA for detection of aflatoxin in corn. Performance Tested Method 050901, AOAC Int, 93, 587, 10.1093/jaoac/93.2.587 · DOI
  36. Ngindu, 1982, Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya, Lancet, 319, 1346, 10.1016/S0140-6736(82)92411-4 · DOI
  37. Quinto, 2009, Determination of aflatoxins in cereal flours by solid-phase microextraction coupled with liquid chromatography and post-column photochemical derivatization-fluorescence detection, J Chromatogr A, 1216, 8636, 10.1016/j.chroma.2009.10.031 · DOI
  38. Kakar F, Akbarian Z, Leslie T, Mustafa ML, Watson J, van Egmond HP, Omar MF, et al. An outbreak of hepatic veno-occlusive disease in western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J Toxicol 2010; ID 313280. DOI: 10.1155/2010/313280 · DOI
  39. Tandon, 1976, An epidemic of veno-occlusive disease of the liver in central India, Lancet, 308, 272, 10.1016/S0140-6736(76)90727-3 · DOI
  40. Tandon, 1987, Veno-occlusive disease of the liver secondary to ingestion of comfrey, Br Med J (Clin Res Ed), 295, 183, 10.1136/bmj.295.6591.183 · DOI
  41. Tandon, 1976, Study of an epidemic of venoocclusive disease in India, Gut, 17, 849, 10.1136/gut.17.11.849 · DOI
  42. Teschke, 2014, Green tea extract and the risk of drug-induced liver injury, Expert Opin Drug Metab Toxicol, 10, 1663, 10.1517/17425255.2014.971011 · DOI
  43. Millonig, 2005, Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia), Eur J Gastroenterol Hepatol, 17, 445, 10.1097/00042737-200504000-00009 · DOI
  44. Martin, 2014, Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster), PLOS One, 9, e111572, 10.1371/journal.pone.0111572 · DOI
  45. Schmidt, 2007, Quality criteria for kava, HerbalGram, 73, 45
  46. Teschke, 2011, Proposal for a Kava Quality Standardization Code, Food Chem Toxicol, 49, 2503, 10.1016/j.fct.2011.06.075 · DOI
  47. Teschke, 2010, Risk of kava hepatotoxicity and the FDA consumer advisory, J Am Med Ass, 304, 2174, 10.1001/jama.2010.1689 · DOI
  48. Teschke, 2012, Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited, Br J Clin Pharmacol, 73, 170, 10.1111/j.1365-2125.2011.04070.x · DOI
  49. Teschke, 2011, Kava, the anxiolytic herb: back to basics to prevent liver injury, Br J Clin Pharmacol, 71, 445, 10.1111/j.1365-2125.2010.03775.x · DOI
  50. Danan, 1993, Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries, J Clin Epidemiol, 46, 1323, 10.1016/0895-4356(93)90101-6 · DOI · Paper page
  51. Bénichou, 1993, Causality assessment of adverse reactions to drugs - II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge, J Clin Epidemiol, 46, 1331, 10.1016/0895-4356(93)90102-7 · DOI · Paper page
  52. Teschke, 2013, Clinical and causality assessment in herbal hepatotoxicity, Expert Opin Drug Saf, 12, 339, 10.1517/14740338.2013.774371 · DOI
  53. Teschke, 2013, Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods, World J Gastroenterol, 19, 2864, 10.3748/wjg.v19.i19.2864 · DOI
  54. Teschke, 2014, Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment, World J Hepatol, 6, 17, 10.4254/wjh.v6.i1.17 · DOI · Paper page
  55. Chalasani, 2015, Features and outcomes of 889 patients with drug-induced liver injury: The DILIN Prospective Study, Gastroenterology, 148, 1340, 10.1053/j.gastro.2015.03.006 · DOI · Paper page
  56. Larson, 2005, Acetaminophen-induced acute liver failure: Results of a United States multicentre, prospective study, Hepatology, 42, 1364, 10.1002/hep.20948 · DOI
  57. Sgro, 2002, Incidence of drug-induced hepatic injuries: a French population-based study, Hepatology, 36, 451, 10.1053/jhep.2002.34857 · DOI · Paper page
  58. Robles-Diaz, 2015, Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids, Aliment Pharmacol Ther, 41, 116, 10.1111/apt.13023 · DOI · Paper page
  59. Bunchorntavakul, 2013, Review article: herbal and dietary supplement hepatotoxicity, Aliment Pharmacol Ther, 37, 3, 10.1111/apt.12109 · DOI · Paper page
  60. Teschke, 2013, Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests, World J Hepatol, 5, 353, 10.4254/wjh.v5.i7.353 · DOI
  61. Avelar-Escobar, 2012, Hepatotoxicity associated with dietary energy supplements: use and abuse by young athletes, Ann Hepatol, 11, 564, 10.1016/S1665-2681(19)31474-7 · DOI
  62. Timcheh-Hariri, 2012, Toxic hepatitis in a group of 20 male body-builders taking dietary supplements, Food Chem Toxicol, 50, 3826, 10.1016/j.fct.2012.07.006 · DOI
  63. Adachi, 2003, Hepatic injury in 12 patients taking the herbal weight loss aids Chaso or Onshido, Ann Intern Med, 139, 488, 10.7326/0003-4819-139-6-200309160-00012 · DOI
  64. Danan G, Teschke R. RUCAM in drug and herb induced liver injuy: the update. Internat J Molec Sci, special issue: Drug, herb, and dietary supplement hepatotoxicity 2015; in press. · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Teschke, R., Schwarzenboeck, A., Frenzel, C., Schulze, J., Eickhoff, A., & Wolff, A.
Venue
Annals of Hepatology
Publisher
Elsevier BV
Published
2016-01
Volume
15
Issue
1
Pages
91-109
ISSN
1665-2681
DOI
10.5604/16652681.1184237
Cited by
29
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review